 VANCOUVER, Dec. 08, 2020 GLOBE NEWSWIRE -- BetterLife Pharma Inc. BetterLife or the Company CSE: BETR OTCQB: BETRF FRA: NPAU an emerging biotech focused on the development and commercialization of revolutionary treatments, today announced the signing of a definitive agreement to acquire 100 of the assets in Transcend Biodynamics LLC Transcend valued at 10 million in an all-stock transaction the Transaction, for a total of 13,333,333 common shares at 0.75 per share. This non-arms length Transaction is subject to the satisfaction or waiver of customary conditions, including regulatory approvals. 